Reports Q4 revenue $167.4M, consensus $189.14M.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PTCT:
- PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
- PTC Therapeutics launches 9th annual STRIVE awards program
- PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference
- PTC Therapeutics provides key 2023 milestones
- PTC Therapeutics sees FY23 revenue $940M-$1B, consensus $865.56M